About the Journal

Field Editor-In-Chief: Wendy Noble, King's College London, UK, Mark P Burns, Georgetown University Medical Center, USA
Abbreviation: Front. Psychiatry
NLM ID: Coming Soon
Indexed in: Google Scholar, PubMed and PsycInfo coming soon

Frontiers in Neurodegenerative Diseases is a specialty section of Frontiers in Psychiatry and Frontiers in Neurology that aims to publish research findings, both basic and clinical, that investigate the cause, progression and treatment of neurodegenerative diseases. We are especially interested in Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, tauopathies and motor neuron disease, as well as rarer neurodegenerative disorders. We will also accept papers in complementary fields including those exploring the mechanisms and pathways involved in neurodegenerative processes following brain injury, such as stroke and trauma.

We have especially strong interest in translational research that enhances our understanding of neurodegenerative diseases through pre-clinical animal studies and small clinical trials. The use of neuroimaging techniques as a tool to follow the progression of disease and identification of peripheral biomarkers are also of high interest. We welcome the results of studies using cell and animal models, human tissues or patients. Genetic, epidemiological, behavioral and biochemical studies are encouraged, as are neuroimaging and microscopy, neuropathology, neurology, pharmacology, physiology and protein chemistry research. Our goal is to provide a forum through which quality research can be disseminated to a wide audience.

Frontiers in Neurodegenerative Diseases welcomes the following tier 1 article types: original research articles, clinical case studies, review articles, hypothesis and theory articles, methods articles, commentaries, perspective articles, opinion articles, book reviews and conference proceedings.

All articles are submitted directly to Frontiers in Neurodegenerative Diseases where they are processed by the associate and review editors of the specialty section. The review process for publishing in the Frontiers journals is unique, with reviewers being revealed upon article publication and acknowledged for their work and their contribution to the publication. There is no selection bias, with an average of 80 days from submission to acceptance, and an average of 7 days from acceptance to final typeset, Frontiers in Neurodegenerative Disease is the fastest way to get your research findings to the scientific community. Articles published in Frontiers in Neurodegenerative Disease are indexed on PubMed and are available free of charge to the entire scholarly community.

All articles published in Frontiers in Neurodegenerative Diseases will be subjected to the Frontiers evaluation system after online publication. Authors of the original research articles with the highest impact, as judged by many expert readers, will be invited by the editor-in-chief of the respective field to write a prestigious Frontiers focused review – a tier 2 article. This is referred to as "democratic tiering". The selection is based on the reader impact over a 3-month period from the date of publication. The selected high impact articles are re-written in a review style centered on the original discovery and aim to address the wider audience.

Frontiers’ philosophy is that all research is for the benefit of mankind. It is enabled by society and should be returned to all people without borders or discrimination. That is why Frontiers provides open and free access to all of its publications. For more information on the open access movement click here.

Under the Frontiers terms and conditions you retain the copyright of your work. This means that you may reproduce copies of your articles in any way you choose and freely disseminate these as reprints, as long as the original publication is fully cited. For instance, your published article can be posted on your personal or institutional homepage, e-mailed to friends and colleagues, printed, archived in a collection, distributed on CD-ROM, quoted in the press, translated and furthermore sent to as many people and as often as you wish.

Each Frontiers article is a landmark of the highest quality, due to true collaborative interactions between authors and the highest quality reviewers. Frontiers recognizes the immense importance of the potential impact of published research on future research and society and, hence, does not support superficial review, light review or no review publishing models. Research knowledge must be validated by peers before entering the stream of knowledge that will eventually reach the public and shape society. Therefore, Frontiers supports the highest quality reviews and operates according to the novel Frontiers academic model that applies a rigorous but unbiased Frontiers review system, a separated, online, automated and global Frontiers evaluation system and Frontiers distillation system, as well as the Frontiers recognition system to reward the most outstanding research selected by the entire community.